Pasireotide Extended-Release Injection and Zoledronic acid
Determining the interaction of Pasireotide Extended-Release Injection and Zoledronic acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pasireotide Extended-Release Injection-Zoledronic Acid (Bone Health)
- Pasireotide Extended-Release Injection-Zoledronic Acid (Zometa)
- Pasireotide Extended-Release Injection-Zoledronic Acid Injection
- Pasireotide Extended-Release Injection-Zoledronic Acid Injection Concentrate
- Pasireotide Extended-Release Injection-Zoledronic acid Intravenous
- Pasireotide Extended-Release Injection-Zoledronic Acid IV
- Zoledronic acid-Pasireotide Injection
- Zoledronic acid-Pasireotide Subcutaneous
- Zoledronic acid-Patanase
- Zoledronic acid-Patiromer
- Zoledronic acid-Patiromer Sorbitex Calcium
- Zoledronic acid-Pavacot